Signal active
Investment Firm
Overview
University of Notre Dame provides a distinctive voice in higher education that is at once rigorously intellectual, unapologetically. The gilded Golden Dome and statue of Mary atop the Main Building proclaim the Notre Dame campus as a place where faith is treasured and diverse traditions shared and respected. Our students represent all 50 states and over 100 countries. Rigorous academics, NCAA Division I athletics, and numerous events and activities create an environment in which our students are ignited with a passion to learn and to live to their fullest capacity.
Notre Dame is one of the few universities to regularly rank in the top 25 in the U.S. News & World Report survey of America's best colleges and the Learfield Sports Directors’ Cup standings of the best overall athletics programs.
Founded in 1842, Notre Dame stands on 1,250 acres considered by many to be among the most beautiful possessed by any university in the nation. From the collegiate Gothic architecture and park-like landscape to exquisite outdoor sculpture and breathtaking views, Notre Dame's campus is a visual splendor.
Notre Dame has a unique spirit. It is traditional, yet open to change. It is dedicated to religious belief no less than scientific knowledge. It has always stood for values in a world of facts. It has kept faith with Father Sorin's vision.
Highlights
1842
Education
5001-10000
2
0
undefined
Early Stage Venture, Seed
N/A
Location
Notre Dame, Indiana, United States, North America
Contact Information
Social
Profile Resume
University of Notre Dame, established in 1842 and headquartered in United States, North America., specializes in Early Stage Venture, Seed investments across Information Technology, Biotechnology, Energy, Media and Entertainment, Financial Services, Venture Capital, Impact Investing, Business Development, Financial Exchanges, Finance. Their recent investments include Connecticut Innovations, Advantage Capital, Gaingels, Ironwood Capital, SoGal Ventures. The highest investment round they participated in was $1.8B. Among their most notable exits are Connecticut Innovations and Advantage Capital. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.
Employees
Investment portfolio
2
1
0
undefined
Investments
2
Annouced Date | Organization Name | Industry | Money Raised |
---|---|---|---|
Feb 07, 2018 | AgenDx Biosciences | Clinical Trials | 675.0K |
Nov 16, 2022 | - | - | 13.0M |
Exits
0
Funding Timeline
2
5
0
Funding Rounds
2
University of Notre Dame has raised 2 rounds. Their latest funding was raised on Nov 16, 2022 from a Series A - Torigen Pharmaceuticals round.
Annouced Date | Transaction Name | Number of Investors | Money Raised | Lead Investor |
---|---|---|---|---|
Feb 07, 2018 | Seed Round - AgenDx Biosciences | - | 675.0K | - |
Nov 16, 2022 | Series A - Torigen Pharmaceuticals | - | 13.0M | - |
Investors
6
University of Notre Dame is funded by 6 investor(s). Lilly Endowment and AmeriCorps Public Allies Kantor are the most recent investors.
Investor Name | Lead Investor | Funding Round | Money Raised |
---|---|---|---|
- | No | Grant - University of Notre Dame | 25.0M |
U.S. Department of Education | Yes | Grant - University of Notre Dame | 2.6M |
AmeriCorps Public Allies | Yes | Grant - University of Notre Dame | 640.1K |
Lilly Endowment | Yes | Grant - University of Notre Dame | 30.0M |
Fund raised
2
Susa Ventures has raised a total of $590M across 6 funds, their latest being Susa Ventures Opportunities II. This fund was announced on Aug 30, 2021 and raised a total of $250M.
Annouced Date | Fund Name | Money Raised |
---|---|---|
May 10, 2013 | OTPPLESS | 1.0M |
May 11, 2013 | OTPPLESS | 1.0M |
Invest in industries